Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-21-011375
Filing Date
2021-05-07
Accepted
2021-05-07 17:30:41
Documents
56
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A rvph20201231b_10ka.htm 10-K/A 1008339
2 EXHIBIT 31.1 ex_247652.htm EX-31.1 10705
3 EXHIBIT 31.2 ex_247653.htm EX-31.2 10794
4 EXHIBIT 32.1 ex_247654.htm EX-32.1 8854
11 auditlogo.jpg GRAPHIC 2573
  Complete submission text file 0001437749-21-011375.txt   4152732

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rvph-20201231.xml EX-101.INS 594825
6 XBRL TAXONOMY EXTENSION SCHEMA rvph-20201231.xsd EX-101.SCH 47944
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rvph-20201231_cal.xml EX-101.CAL 27461
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvph-20201231_def.xml EX-101.DEF 339493
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvph-20201231_lab.xml EX-101.LAB 282984
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvph-20201231_pre.xml EX-101.PRE 358954
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 2127105220
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38634 | Film No.: 21904186
SIC: 2834 Pharmaceutical Preparations